VKH
CCXI

Virtu KCG Holdings’s ChemoCentryx, Inc. CCXI Stock Holding History

Virtu KCG Holdings’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-59,051
Closed -$437K – 3926
2016
Q4 		$437K Buy
59,051
+38,194
+183% +$275K 0.01% 1656
2016
Q3 		$126K Buy
+20,857
New +$98.6K ﹤0.01% 2559
2015
Q3 		– Sell
-10,381
Closed -$85K – 3958
2015
Q2 		$85K Buy
+10,381
New +$82.5K ﹤0.01% 2961
2015
Q1 		– Sell
-27,387
Closed -$187K – 4057
2014
Q4 		$187K Buy
+27,387
New +$145K ﹤0.01% 2922
2014
Q3 		– Sell
-11,312
Closed -$66K – 4208
2014
Q2 		$66K Sell
11,312
-6,112
-35% -$34.3K ﹤0.01% 3382
2014
Q1 		$115K Buy
17,424
+4,817
+38% +$33.5K ﹤0.01% 3171
2013
Q4 		$73K Buy
+12,607
New +$65K ﹤0.01% 3526

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu KCG Holdings's CCXI Position: Q1 2017 in Review

Virtu KCG Holdings sold out of ChemoCentryx, Inc. (CCXI) in Q1 2017, closing a stake of 59,051 shares — an estimated $437K sold.

Virtu KCG Holdings first reported a position in CCXI in Q4 2013 and held it in 7 quarters. The position peaked at $437K in Q4 2016. 84 funds tracked by Wall St. Rank hold CCXI as of Q1 2017.

  • Virtu KCG Holdings reported no remaining ChemoCentryx, Inc. position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 59,051 ChemoCentryx, Inc. shares in Q1 2017, an estimated $437K.
  • Virtu KCG Holdings first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 7 quarters.
  • Virtu KCG Holdings's ChemoCentryx, Inc. position peaked at $437K in Q4 2016.
  • 84 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.